Cannabis Regulations (SOR/2018-144)

Marginal note:Retention period

• 195 (1) Subject to subsections (2) and (3), an individual in charge of a hospital must ensure that the records that the individual is required to retain under this Part are retained for at least two years after the day on which they are prepared.

• Marginal note:Ceasing to act

  (2) If the individual in charge of the hospital ceases to act in that capacity at the hospital where the records are prepared, the individual who replaces that individual must ensure that any records for which the two-year retention period has not ended are retained for the remainder of that retention period.

• Marginal note:Ceasing operations

  (3) If the hospital ceases its operations, the person responsible for those operations on the date those operations cease must ensure that any records for which the two-year retention period has not ended are retained for the remainder of that retention period.

Licensed Dealers

Marginal note:Record keeping — drug received

195.1 A licensed dealer that receives a drug containing cannabis must enter the following in a record retained for such purposes:

• (a) the proper name or common name of the drug or, in the case of a prescription drug, its brand name and drug identification number;

• (b) the form, quantity and strength per unit of the drug received;

• (c) the name and address of the person from which the drug was received; and

• (d) the date of receipt.

Marginal note:Sale or distribution for destruction

• 195.2 (1) A licensed dealer, other than a licensed dealer specialized in destruction, may sell or distribute a drug containing cannabis, in accordance with a written order, to a licensed dealer specialized in destruction if the drug is sold or distributed for the purpose of its destruction.

• Marginal note:Written order

  (2) The written order must contain

  • (a) the proper name or common name of the drug or, in the case of a prescription drug, its brand name and drug identification number;

  • (b) the quantity and strength per unit of the drug; and

  • (c) an attestation that states that the sole purpose of the order is the destruction of the drug and that is signed and dated by, or on behalf of, the licensed dealer specialized in destruction.

• Marginal note:Record keeping

  (3) The licensed dealer referred to in subsection (1) that sells or distributes the drug must prepare a record that sets out

  • (a) the proper name or common name of the drug or, in the case of a prescription drug, its brand name and drug identification number;

  • (b) the form, quantity and strength per unit of the drug;

  • (c) the name and address of the person to which it was sold or distributed; and

  • (d) the date on which it was sold or distributed.

Marginal note:Retention period

195.3 The licensed dealer must retain the records referred to in section 195.1 and subsection 195.2(3) for at least two years after the day on which they are prepared.

DIVISION 3Importation and Exportation by Travellers

Marginal note:Importation

195.4 On entering Canada, an individual may import a drug containing cannabis that is in their actual possession or that forms part of their baggage if

• (a) the individual is importing the drug

  • (i) for their own use,

  • (ii) for the use and on behalf of an accompanying individual, or

  • (iii) for administration to an animal for which the individual is responsible and that is accompanying the individual;

• (b) the drug is declared to a customs officer at the port of entry into Canada;

• (c) the drug is in a container obtained from a health care provider and carrying a label on which the following information appears:

  • (i) the name of the individual for whom, or the animal for which, the drug was lawfully obtained,

  • (ii) the name of the health care provider who authorized the drug to be obtained,

  • (iii) the proper name or common name of the drug or, in the case of a prescription drug, its brand name and, if any, its drug identification number,

  • (iv) the form, quantity and strength per unit of the drug, and

  • (v) the daily dose authorized by the health care provider; and

• (d) the imported quantity of the drug does not exceed a 90-day supply required to treat a condition, based on the daily dose shown on the label.

Marginal note:Exportation

195.5 On departing Canada, an individual may export a drug containing cannabis that is in their actual possession or that forms part of their baggage if

• (a) the individual is exporting the drug

  • (i) for their own use,

  • (ii) for the use and on behalf of an accompanying individual, or

  • (iii) for administration to an animal for which the individual is responsible and that is accompanying the individual;

• (b) the drug is in a container obtained from a health care provider and carrying a label on which the following information appears:

  • (i) the name of the individual for whom, or the animal for which, the drug was lawfully obtained,

  • (ii) the name of the health care provider who authorized the drug to be obtained,

  • (iii) the proper name or common name of the drug or, in the case of a prescription drug, its brand name and, if any, its drug identification number,

  • (iv) the form, quantity and strength per unit of the drug, and

  • (v) the daily dose authorized by the health care provider; and

• (c) the exported quantity of the drug does not exceed a 90-day supply required to treat a condition, based on the daily dose shown on the label.

PART 9Combination Products and Devices

196 [Repealed, SOR/2025-244, s. 38]

Marginal note:Authorization

197 Subject to the other provisions of these Regulations, a person may promote a combination product by communicating the brand name, proper name, common name, price or quantity of the product.

Marginal note:Exemption — section 21 of Act

198 A person is exempt from the application of section 21 of the Act if they display, refer to or otherwise use the brand name of a combination product, or the name of the holder of the drug identification number for the product, directly or indirectly in a promotion that is used in the sponsorship of a person, entity, event, activity or facility.

Marginal note:Exemption — section 22 of Act

199 A person is exempt from the application of section 22 of the Act if they display on a facility, as part of the name of the facility or otherwise, if the facility is used for a sports or cultural event or activity, the brand name of a combination product or the name of the holder of the drug identification number for the product.

Marginal note:Exemption — subsection 23(1) of Act

200 A person is exempt from the application of subsection 23(1) of the Act if they publish, broadcast or otherwise disseminate, on behalf of another person, with or without consideration, any promotion that is authorized under sections 197 to 199.

Marginal note:Authorization — combination product for veterinary use

201 Subject to the other provisions of these Regulations, a person that is authorized to sell a combination product for veterinary use may sell it in a package or with a label that sets out a depiction of a real or fictional animal that corresponds to the species of the animal for which the product is intended.

Marginal note:Authorization — combination product

• 202 (1) Subject to the other provisions of these Regulations, a person is authorized to sell a combination product to a young person.

• Marginal note:Authorization — device

  (2) Subject to the other provisions of these Regulations, a person is authorized to sell a device licensed for use with a prescription drug to a young person if the person

  • (a) has ascertained that there is a written prescription for the young person with respect to the drug; and

  • (b) is entitled under the laws of a province to dispense a prescription drug.

PART 10Importation and Exportation for Medical or Scientific Purposes

Definitions

Marginal note:Definitions

203 The following definitions apply in this Part.

customs office

customs office has the same meaning as in subsection 2(1) of the Customs Act. (bureau de douane)

customs officer

customs officer has the meaning assigned by the definition officer in subsection 2(1) of the Customs Act. (agent des douanes)

Importation

Marginal note:Import permit

• 204 (1) A holder of a licence is authorized to import cannabis for medical or scientific purposes if they also hold an import permit for each shipment of cannabis that is imported.

• Marginal note:Ancillary activities

  (2) A holder of an import permit is also authorized to possess, transfer, transport, send or deliver the shipment of cannabis to the extent necessary to import the cannabis.

Marginal note:Import permit — content

205 The import permit must set out the following information:

• (a) the name and mailing address of the holder;

• (b) the permit number and the licence number;

• (c) in respect of the shipment of cannabis to be imported,

  • (i) a description of the cannabis,

  • (ii) the intended use of the cannabis,

  • (iii) if applicable, the brand name of the cannabis,

  • (iv) in the case of a drug containing cannabis, other than a prescription drug, the proper name or common name of the drug,

  • (v) in the case of a prescription drug, the brand name of the drug and its identification number,

  • (vi) the quantity of the cannabis, and

  • (vii) the percentages of THC w/w and CBD w/w of the cannabis, except in the case of cannabis plants and cannabis plant seeds;

• (d) the name and address of the exporter in the country of export;

• (e) [Repealed, SOR/2025-43, s. 59]

• (f) [Repealed, SOR/2025-43, s. 59]

• (g) each mode of transportation used, the country of export and, if applicable, any country of transit or transhipment;

• (h) any conditions that the Minister considers appropriate;

• (i) the effective date of the permit; and

• (j) the date of expiry of the permit.

Marginal note:Refusal to issue — other grounds

206 For the purpose of paragraph 62(7)(h) of the Act, other grounds for refusing to issue an import permit are the following:

• (a) the applicant does not hold a licence; and

• (b) the Minister has reasonable grounds to believe that

  • (i) the shipment to which the permit application pertains would contravene these Regulations or the laws of the country of export or any country of transit or transhipment, or

  • (ii) the importation of the cannabis is for the purpose of exporting it.

Marginal note:Period of validity

207 An import permit is valid until the earliest of the following dates:

• (a) the date on which the shipment is imported,

• (b) the date of expiry of the permit or the date of its revocation,

• (c) the date of expiry of the licence referred to in paragraph 205(b) or the date of its revocation, or

• (d) the date of revocation of the permit for exportation issued by the competent authority of the country of export that pertains to the shipment.

Marginal note:Provision of copy of import permit

208 A holder of an import permit must provide a copy of the import permit to the customs office at the time of importation.

Marginal note:Information

209 The holder of an import permit must, within 15 days after the date of release of a shipment of cannabis in Canada, provide the Minister with the following information:

• (a) their name, the number of the licence referred to in paragraph 205(b) and the import permit number issued in respect of the shipment;

• (b) the date of release of the shipment; and

• (c) in respect of the shipment of cannabis that is imported,

  • (i) a description of the cannabis,

  • (ii) the intended use of the cannabis,

  • (iii) if applicable, the brand name of the cannabis,

  • (iv) in the case of a drug containing cannabis, other than a prescription drug, the proper name or common name of the drug,

  • (v) in the case of a prescription drug, the brand name of the drug and its drug identification number,

  • (vi) the quantity of the cannabis, and

  • (vii) the percentages of THC w/w and CBD w/w of the cannabis, except in the case of cannabis plants and cannabis plant seeds.